The CDC has released its outlook for the 2025-26 respiratory disease season. Reports suggest that covid-19 hospitalizations may be higher this season, and the current flu vaccine has been found to be 30% effective in reducing adult hospitalizations and 41% for children. The effectiveness of other treatments, such as nirsevimab in preventing RSV-associated ICU admissions, has also been reported, with some data indicating an 80% effectiveness rate.